LONDON AstraZeneca said on Monday its COVID-19 vaccine was 70% effective in pivotal trials and could be up to 90% effective, giving the world's fight against the global pandemic a third new weapon that can be cheaper to make, easier to distribute and faster to scale-up than rivals. | Video
London/Frankfurt Auf der Suche nach einem Impfstoff gegen das Coronavirus hat mit AstraZeneca ein weiteres Pharmaunternehmen einen Studienerfolg erzielt.
London/Frankfurt Auf der Suche nach einem Impfstoff gegen das Coronavirus hat mit AstraZeneca ein weiteres Pharmaunternehmen einen Studienerfolg gemeldet.
LONDON Most people would get a COVID-19 vaccine if their government or employer recommended it, results of a global poll showed on Tuesday, amid growing concerns about public distrust of the shots being developed at speed to end the pandemic.
LONDON Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose existing drugs as potential coronavirus therapies.
LONDON Britain will buy potential COVID-19 vaccines from U.S. drugmakers Johnson & Johnson and Novavax Inc , the companies said on Friday, boosting the number of deals it has with drugmakers as the global vaccine race rages on.
BRUSSELS/LONDON The frenetic race to develop a COVID-19 vaccine has intensified safety concerns about an inoculation, prompting governments and drugmakers to raise awareness to ensure their efforts to beat the coronavirus aren't derailed by public distrust.